FDA Inspection
Octapharma Plasma IncOctapharma Plasma Inc – FDA Inspection, Sep 17, 2014
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on September 17, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma Inc
- Inspection Date
- September 17, 2014
- Product Type
- Biologics
View Company Profile
ID · 375d50ca-4da7-49cb-ac5d-51d2c2c13b00
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 897084
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(a)(2)Determination of lot numbers and supplies
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 13, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma Inc
- FDA Inspection 1099767 - 2019-07-24
- FDA Inspection 800541 - 2012-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.